Yes Defined protocol followed: Yes Measure of treatment fidelity reported: Yes Co-interventions held stable during treatment: Yes, n Inclusion criteria: • chronological age between 7 and 14 years • confirmed diagnosis of ASD, determined by one of three expert clinical psychologists using recent ADOS and SCQ • speaking in full complex sentences reflected in recent standardized cognitive assessment • clinically significant symptoms of anxiety (score above clinical significance cutoff on separation, social and/or generalized anxiety subscales of the SCARED Exclusion criteria: • see above Age, mean ± SD months: G1: 125.75 ± 21.47 G2: 125.00 ± 20.45 Mental age, mean/yrs (range): NR Sex: M, n (%) G1: 24 (100) Anxiety Disorders Interview schedule for children Separation G1: 2.45 ± 2.33 (0-5) G2: 2.22 ± 2.49 (0-6) Social G1: 3.85 ± 2.13 (0-6) G2: 3.70 ± 2.36 (0-7) Specific phobia G1: 3.45 ± 2.35 (0-7) G2: 3.09 ± 2.09 (0-6) Generalized anxiety G1: 4.46 ± 2.02 (0-7) G2: 5.09 ± 1.44 (0-7) ADIS-P principal anxiety diagnoses (SAP, SOC, GAD, SpP) G1: 2.90 ± 0.91 (1-4) G2: 2.91 ± 0.95 (1-4) Anxiety Disorders Interview schedule for children Separation G1: 1.05 ± 1.90 (0-5) G2: 1.87 ± 2.70 (0-7) Social G1: 2.40 ± 2.30 (0-5) G2: 3.61 ± 2.55 (0-7) Specific phobia G1: 1.88 ± 1.80 (0-6) G2: 3.65 ± 1.70 (0-6) Generalized anxiety G1: 2.55 ± 2.50 (0-6) G2: 4.61 ± 1.70 (0-7) ADIS-P principal anxiety diagnoses (SAP, SOC, GAD, SpP) G1: 2.25 ± 0.91 (1-4) G2: 2.83 ± 0.98 (1-4) Harms: NR Modifiers: NR C-106 G1: 23 G2: 23 Concomitant therapies, n (%): Psychiatric medication use - any G1: 10 G2: 14 SSRI G1: 5 G2: 7 Atypical antipsychotic G1: 4 G2: 3 Stimulant G1: 5 G2: 4 Anticonvulsants G1: 1 G2: 3 Alpha-blockers G1: 1 G2: 5 Mood stabilizers G1: 0 G2: 1 N at enrollment: G1: 24 G2: 26 N at follow-up: G1: 21 G2: 26 G2: 24 (92.3) F, n (%) G1: 0 G2: 2 (7.7) Race/ethnicity, n (%): White G1: 22 (91.7) G2: 20 (76.9) Asian/Pacific Islander G1: 0 G2: 1 (3.8) African-American G1: 1 (4.2) G2: 2 (7.7) Multi-racial G1: 1 (4.2) G2: 3 (11.5) SES: Maternal education: Graduated from college, n(%): G1: 15 (62.5) G2: 15 (57.7) Diagnostic approach: In Study/Referral Diagnostic tool/method: Diagnostic category, n (%): Autistic disorder G1: 16 (67.7) G2: 15 (58.9) PDD-NOS C-107 N for analysis (ITT): G1: 24 G2: 26 G1: 0 G2: 3 (11.5) Asperger syndrome G1: 8 (33.3) G2: 8 (30.8) Other characteristics: Full scale IQ estimate, mean ± SD (range): G1: 107.08 ± 16.85 (70- 139) G2: 102.23 ± 17.33 (70- 134) Verbal IQ, mean ± SD (range): G1: 107.00 ± 19.51 (65- 133) G2: 100.73 ± 18.98 (67- 134) Nonverbal IQ, mean ± SD (range): G1: 109.67 ± 16.38 (75- 133) G2: 105.04 ± 17.86 (70- 134) # Psychiatric diagnoses other than ASD G1: 1-7 G2: 2 - 8 C-108 Table C-1. Evidence table, continued Study Description Intervention Inclusion/ Exclusion Criteria/ Population Baseline Measures Outcomes Author: